药品价格透明度数据的有用性有限
Yuvraj Pathak1, Elvira Makk Frid2, Nico Gabriel3
1West Health Institute, La Jolla, CA.
Journal of managed care & specialty pharmacy
|March 28, 2025
概括
医院价格透明度数据揭示了报告提供商管理的药品报销率存在重大问题. 不一致的单位和缺少的信息阻碍了准确的价格评估,在使用这些数据时需要谨慎.
科学领域:
- 卫生经济学 卫生经济学
- 医疗保健政策 医疗保健政策
- 制药价格的制定 制药价格的制定
背景情况:
- 医院价格透明规则规定,自2021年以来,必须报告包括药品在内的常用服务价格.
- 评估由提供者管理的药物的报销变化对于了解医疗保健成本至关重要.
研究的目的:
- 评估医院价格透明度数据的可用性,以分析提供者管理的药物的报销率变化.
- 确定影响药品定价准确解释的数据质量问题.
主要方法:
- 使用的医院价格透明度数据由Turquoise Health汇总.
- 提取了与提供者管理的药物相关的30个程序代码的记录,其中有超过1000个国家提供者识别 (NPI).
- 评估报告率的变化,并确定缺失或不一致的数据点 (NPI,报销率,国家药物规范).
主要成果:
- 在3,321,502个提取的记录中,65%缺乏必要的NPI,退款率或国家药物规范 (NDC) 信息.
- 其余35%的NDC数据通常没有报告NDC单位的谈判利率.
- 价格以多个不一致的数量报告,包括程序代码单位,NDC单位和总的药物量.
结论:
- 重要的数据质量问题,包括缺失的信息和不一致的单位,限制了医院价格透明度数据的当前可用性,用于评估提供商管理的药品报销.
- 需要标准化报告要求,以确保准确的价格比较,并防止对药品定价的错误推断.
相关概念视频
01:19Pharmacovigilance
732
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
732
01:25Drug Regulation
1.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.2K
01:02Prescription, Nonprescription and Orphan Drugs
651
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
651
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
19
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
19
01:29Drug Distribution: Plasma Protein Binding
4.3K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
4.3K
01:17Drug Nomenclature
1.5K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.5K